Eupraxia Pharmaceuticals Inc. (EPRX)

NASDAQ: EPRX · Real-Time Price · USD

Compare

8.46

-0.33 (-3.75%)

At close: Feb 5, 2026, 4:00 PM EST

8.37

-0.09 (-1.06%)

After-hours: Feb 5, 2026, 6:07 PM EST

Eupraxia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	88.96	33.1	19.34	18.26	16.51	0.12
Short-Term Investments	-	-	-	-	7.12	-
Cash & Short-Term Investments	88.96	33.1	19.34	18.26	23.63	0.12
Cash Growth	927.03%	71.14%	5.91%	-22.70%	19954.27%	-86.78%
Other Receivables	0.14	0.23	0.19	0.09	0.34	0.49
Receivables	0.14	0.23	0.19	0.09	0.34	0.49
Prepaid Expenses	2.3	1.11	0.27	0.24	0.21	0.29
Total Current Assets	91.4	34.44	19.8	18.59	24.18	0.89
Property, Plant & Equipment	0.85	0.42	0.46	0.53	0.47	0.25
Other Long-Term Assets	0.1	0.08	0.01	0	0.02	-
Total Assets	92.35	34.94	20.27	19.12	24.67	1.14
Accrued Expenses	3.71	3.01	3.87	2.91	1.67	2.38
Short-Term Debt	-	-	-	-	-	9.82
Current Portion of Long-Term Debt	-	-	10.4	0.08	0.08	-
Current Portion of Leases	0.08	0.07	0.05	0.05	0.05	0.04
Current Income Taxes Payable	-	-	0.04	-	-	-
Other Current Liabilities	0.03	0.02	5.02	0.02	0	5.44
Total Current Liabilities	3.81	3.1	19.37	3.06	1.79	17.69
Long-Term Debt	-	-	-	8.8	7.66	-
Long-Term Leases	0.09	-	-	0.05	0.11	0.16
Other Long-Term Liabilities	-	-	-	-	-	0.3
Total Liabilities	3.91	3.1	19.37	11.91	9.56	18.14
Common Stock	191.02	116.36	92.91	71	61.36	18.68
Additional Paid-In Capital	23.47	20.5	17.51	16.85	-	4.86
Retained Earnings	-152.87	-131	-105.5	-77.28	-58.68	-40.18
Comprehensive Income & Other	-3.3	-4.16	-2.71	-2.79	13.09	-
Total Common Equity	58.32	1.7	2.22	7.79	15.77	-16.65
Minority Interest	-1.59	-1.57	-1.32	-0.58	-0.66	-0.36
Shareholders' Equity	88.44	31.84	0.89	7.21	15.11	-17
Total Liabilities & Equity	92.35	34.94	20.27	19.12	24.67	1.14
Total Debt	0.17	0.07	10.45	8.99	7.9	10.02
Net Cash (Debt)	88.79	33.03	8.89	9.28	15.73	-9.9
Net Cash Growth	936.19%	271.55%	-4.18%	-41.03%	-	-
Net Cash Per Share	2.46	0.97	0.37	0.48	1.27	-1.62
Filing Date Shares Outstanding	50.65	35.85	35.62	27.36	14.24	12.87
Total Common Shares Outstanding	50.6	35.64	27.28	21.59	14.24	6.18
Working Capital	87.59	31.33	0.43	15.53	22.39	-16.8
Book Value Per Share	1.15	0.05	0.08	0.36	1.11	-2.69
Tangible Book Value	58.32	1.7	2.22	7.79	15.77	-16.65
Tangible Book Value Per Share	1.15	0.05	0.08	0.36	1.11	-2.69
Buildings	-	-	-	-	0.07	0.07
Machinery	1.14	0.7	0.68	0.61	0.1	0.07
Leasehold Improvements	0.13	0.12	0.13	0.13	0.13	0.08

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q